XXII logo

22ND CENTURY GROUP INC

XXIINASDAQ
🏆 #5079 by market capEarnings Nov 2US Equity
——
Quote unavailable
🔔
Track XXII
Get earnings, price moves & breaking news on Telegram
Track
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$4M
Small Cap
📈Revenue Growth (YoY)
-27.4%
Declining
📊Gross Margin
-19.4%
Thin
💵FCF Margin
—
⚖️P/S Ratio
0.0x
Cheap
Otter Score
—
Insufficient data
No chart data available for XXII.

Trading Snapshot

Day Range
—
52-Week Range
$0.09 – $540.00
Volume (shares)
—
Avg Volume (shares)
—
Shares Outstanding
19.2M
Next Earnings
2026-11-02

Fundamentals Snapshot

Annual Revenue
—
Last Q Revenue
—
P/E Ratio
—
P/S Ratio
0.0x
EPS (TTM)
$221.66
Dividend Yield
—
Dilution (1yr)
+40579.3%
XXII logo

22ND CENTURY GROUP INC

XXII
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$7M▼ −40.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-44.5%▲ +120.3% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$11M▼ −18.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$9M▼ −40.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
472K▲ +40579.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3M▲ +$7M YoY
StockOtter · stockotter.space

About 22ND CENTURY GROUP INC

22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.